Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes
Description
In this Product Explainer, Endocrinologist Prof Richard O’Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Expert panel – Dr Georgia Rigas & A/Prof Samantha Hocking, facilitated by Dr Angela Kwong
Weight Management in Women of Reproductive Age
Jarrod Warner & Irene Schneider
New Spirometry Standards: Key Changes for Clinical Practice
A/Prof Alberto Pinzon Charry
Food Allergy Prevention
A/Prof Daryl Cheng
Protecting Young Lungs – Paediatric Insights into RSV
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
Endocrinologist; Clinical Dean of Medicine, University of Melbourne, Austin Clinical School; Director of Graduate Programs, Melbourne Medical School; Senior Endocrinologist and Director, Lipid Service, Austin Health
